Pascal Soriot and John Zimmer represent two very different paths to global business success. Soriot built his reputation in the pharmaceutical industry, rising from veterinary medicine into senior leadership at Roche, Genentech and AstraZeneca. Zimmer took a technology and hospitality-focused route, eventually co-founding Lyft and helping shape modern ride-hailing. Their backgrounds, education, careers and public profiles differ considerably, while both have become influential figures in their respective industries. The comparison below brings together the key verified details in one straightforward profile.
Pascal Soriot and John Zimmer Quick Bio
| Profile Detail | Pascal Soriot | John Zimmer |
| Full Name | Pascal Claude Roland Soriot | John Zimmer |
| Date of Birth | May 23, 1959 | March 14, 1984 |
| Age | 67 years (2026) | 42 years (2026) |
| Net Worth (Estimated) | No reliably verified public net-worth figure. His wealth should not be confused with his executive compensation. AstraZeneca disclosed substantial annual remuneration, including salary, bonuses and share awards. | No reliably verified current public net-worth figure. His wealth is principally associated with his Lyft holdings, investments and entrepreneurial career. |
| Birthplace | France, in the Paris area | Greenwich, Connecticut, USA |
| Nationality | French and Australian | American |
| Profession | Pharmaceutical executive, business leader and veterinarian | Entrepreneur, technology executive and investor |
| Famous For | Serving as AstraZeneca’s CEO since October 2012 and leading the company’s global pharmaceutical business. | Co-founding Lyft and helping build it into a major ride-hailing company. He later became Vice Chair of Lyft’s Board. |
| Current Position | Executive Director and CEO of AstraZeneca. | Vice Chair of Lyft’s Board; he stepped away from the President role in June 2023. |
| Education | Doctor of Veterinary Medicine and MBA from HEC Paris, with a finance specialization. | B.S. in Hotel Administration from Cornell University. |
| Early Career | Began as a veterinarian, then entered the pharmaceutical industry in 1986. | Worked as a real-estate finance analyst at Lehman Brothers before building his entrepreneurial career. |
| Major Career Roles | Senior management positions at Roussel Uclaf/Hoechst Marion Roussel; CEO of Genentech; COO of Roche’s pharmaceutical division; later CEO of AstraZeneca. | Co-founder of Lyft; former COO, former President, and current Vice Chair of Lyft. |
| Career Start | Pharmaceutical industry career began in 1986 after veterinary practice. | Entered finance before moving into entrepreneurship and transportation technology. |
| Parents | His father was a tax collector and his mother was a homemaker, according to biographical accounts. | Publicly available authoritative sources provide limited information about his parents. |
| Siblings | Reported to have three brothers. | Reliable public information about siblings is limited. |
| Family | Married with two children, according to published biographical profiles. | Married with a daughter, according to widely published biographical information. |
| Marital Status | Married | Married |
| Children | Two | One daughter |
| Hobbies / Interests | Cycling, horse riding and skiing are among interests associated with him. | Strong professional interests in hospitality, transportation, mobility and urban travel. |
| Nickname | No reliably documented public nickname | No reliably documented public nickname |
| Height | Not reliably documented by authoritative sources | Not reliably documented by authoritative sources |
| Weight | Not reliably documented | Not reliably documented |
| Hair Color | Not reliably documented | Not reliably documented |
| Eye Color | Not reliably documented | Not reliably documented |
| No verified official public Instagram account established | No verified official Instagram account established | |
| Business / Company | AstraZeneca | Lyft |
| Role in Company | CEO and Executive Director of AstraZeneca since October 2012. | Co-founder and Vice Chair; previously COO and President. |
| Leadership Achievement | Credited with helping transform AstraZeneca into a major global scientific and pharmaceutical company, including expansion of its research and medicine portfolio. | Helped establish and scale Lyft from its early transportation concept into a major ride-hailing platform. |
| Major Recognition | Knight Bachelor, awarded in 2022 for services to UK life sciences and leadership in the global COVID-19 response. | Best known for his entrepreneurial contribution to Lyft and the transportation-technology sector. |
| Leadership Background | Global pharmaceutical leadership spanning Europe, Australia, Asia and the United States. | Combines finance, hospitality education, entrepreneurship and technology leadership. |
| Public Profile | A prominent global pharmaceutical executive whose career is closely associated with AstraZeneca. | A prominent technology entrepreneur associated primarily with Lyft. |
| Height & Appearance Note | Reliable corporate biographies do not publish verified height, weight, hair or eye measurements. | Reliable corporate biographies do not publish verified height, weight, hair or eye measurements. |
| Last Word Information | Pascal Soriot’s career stands out for its unusual combination of veterinary medicine, business education and global pharmaceutical leadership. His long tenure as AstraZeneca CEO has made him one of the most recognizable executives in the international life-sciences industry. | John Zimmer’s defining achievement is Lyft, which he co-founded and helped develop from an early transportation idea into a major technology company. He remains involved with Lyft as Vice Chair after leaving his full-time President position in 2023. |


